Inflammatory mediators, including circulating tumor necrosis factor alpha (TNF-α), TNF receptor 1(TNFR1), and serum amyloid A, are emerging as potential biomarkers and therapeutic targets for DKD (Alicic et al., 2018). Here, TNF is linked to diabetic kidney disease.